Skip to content

Motor-cognitive Dual-task in Healthy Older Adults and Early Parkinson's Disease Patients

TwinBrain Parkinson's Disease Clinical Trial

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05477654
Acronym
TwinBrainPD
Enrollment
60
Registered
2022-07-28
Start date
2022-08-01
Completion date
2023-10-30
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Motor Disorders, Parkinson Disease

Brief summary

Neuromuscular dysfunction is common in older adults and even more pronounced in neurodegenerative diseases. In Parkinson's disease (PD), a complex set of factors often prevents effective performance of activities of daily living that require intact and simultaneous performance of motor and cognitive tasks. In the current study we aim at employing the Mobile Brain/Body Imaging approach (MoBI) to gain further insides of neuromuscular biomarkers revealing the decrements of older adults with an early PD. The cross-sectional study will be evaluated through the multifactorial mixed-measure design.

Interventions

DIAGNOSTIC_TESTExtensive motor-cognitive testing protocol

Screening of their functional performance while monitoring brain and muscle activity

Sponsors

Technische Universität Berlin
CollaboratorOTHER
University of Geneva, Switzerland
CollaboratorOTHER
University of Trieste
CollaboratorOTHER
University Maribor
CollaboratorOTHER
Science and Research Centre Koper
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria for the healthy older participants will be: * no diagnosis of cognitive or movement disorder, * score \> 7 for the Short Physical Performance Battery (SPPB), * living independently in the community, * age range between 55 and 70 years, * no color blindness. Inclusion criteria for the early-stage PD patients: * diagnosed according to the last MDS criteria (2015), * duration of the disease less than 5 years, * positive DATSCAN, * diagnosed akinetic-rigid or mixed phenotype, * score of 1 or maximally 2 on the Hoehn and Yahr scale (Hoehn & Yahr, 1967), * MoCA score ≥ 24 points, * score \> 7 for the SPPB, * age range between 50 and 75 years, * no color blindness * living independently in the community.

Exclusion criteria

* advanced stages of PD (Hoehn and Yahr score \> 2) * any acute or chronic diseases, especially of the peripheral and central nervous system, heart failure, respiratory failure, severe osteoarthritis, and major psychiatric illness such as depression * MoCA score \< 24 points, * severe disabling tremor, * recurrent falls, * impaired vision that is not corrected with e.g., glasses, * low SPPB score

Design outcomes

Primary

MeasureTime frameDescription
dual-task costs while walkingDay 1Test for dual-task costs associated with the concurrent execution of overground walking and a secondary cognitive task
dual-task costs while standingDay 1Test for dual-task costs associated with the concurrent execution of semi-tandem stance and a secondary cognitive task
dual-task costs while execution of isometric taskDay 1Test for dual-task costs associated with the concurrent execution of isometric contraction and a secondary cognitive task

Secondary

MeasureTime frameDescription
The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS)Day 1Assessment of various aspects of PD including motor and non-motor experience of daily living and the related complications

Countries

Slovenia

Contacts

Primary ContactUros Marusic, PhD
uros.marusic@zrs-kp.si+386 5 66 37 700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026